Skip navigation links
Faculty
Divisions
Patient Care
Research
Education
Conferences
Administration
Skip navigation links
Grant Support
Publications
Kawasaki Disease
Research Activities 

Seema S. Aceves, M.D., Ph.D.

- Study of eosinophilic esophagitis: its pathogenesis (the role of pro-inflammatory and pro-fibrotic molecules), diagnosis (biomarker discovery) and treatment (topical budesonide)
- A randomized, placebo-controlled trial of oral viscous budesonide versus proton pump inhibito therapy in pediatric eosinophilic esophagitis
- Multi-center clinical trials on the use of anti-IL-5 in pediatric eosinophilic esophagitis
- Principal investigator, San Diego County study of the clinical characteristics of eosinophilic esophagitis
- Executive Counsel member, The International Gastrointestinal Eosinophil Reserch network

John F. Bastian, M.D.
- Difficult asthma
- Immunodeficiency disorders
- Kawasaki disease

Jane C. Burns, M.D.
- The pathophysiology, immunology, diagnosis, etiology, treatment, genetics, epidemiology and history of Kawasaki disease
- A multicenter, randomized placebo-controlled clinical trial of infliximab plus IVIG for primary treatment of Kawasaki disease
- Call-back study of adolescents and young adults with a history of Kawasaki disease in childhood

Alessandra M. Franco, M.D., Ph.D.
- Cytotoxic T cell biology
- Carbohydrate T cell recognition
- Designer glycopeptides containing tumor-associated carbohydrate antigens as vaccines for prevention/treatment of epithelial cancer
- Epitope glycosylation to bypass the effects of viral mutations (HIV and HBV as models) in antiviral vaccines
- T-cell repertoire in Kawasaki disease

Hal M. Hoffman, M.D.
- Role of innate immunity in autoinflammatory disorders
- Genetic basis of familial cold autoinflammatory syndrome (FCAS) and other cryopyriopathies
- Role of IL-1 targeted therapy in cryopyrinopathy patients (has resulted in an effective new therapy for these patients.)
- Primary consultant, a multicenter, phase III trial of IL-1 TRAP, a novel IL-1 blocker in 40-50 FCAS patients in North America
- Genetic basis of rare inherited disorders including congenital diarrheas, rare urticarial disorders, and autoinflammatory disorders
- Inflammatory mechanisms involved in periodic fever disorders of childhood

Anthony A. Horner, M.D.
- Characterization of the molecular content and immunological activities of sterile house dust extracts to better define the immunomodulatory role living environments have on the genesis of allergic diseases
- Translational studies to determine if house dust extract bioactivities are predictive of the intrinsic allergic risk associated with being raised in their homes of origin
- Treatment of allergic diseases with toll-like receptor ligands and other immunomodulatory molecules

Chisato Shimizu, Ph.D.
- Genetics and molecular pathogenesis of Kawasaki disease

Ilona S. Szer, M.D.
- Conducts several clinical trials of new treatments for juvenile arthritis and pediatric rheumatologic diseases

Robert M. Sheets, M.D.
- Clinical trials of new treatments for pediatric rheumatologic diseases, currently involved in the TREAT study